Another approach involves the use of oxygen-generating or oxygen-carrying nanocarriers, such as catalase (CAT) and perfluorocarbons (PFCs), to produce or deliver oxygen directly into hypoxic regions, improving tumor oxygenation and sensitizing tumor cells to treatment [65, 81, 149]. The gene discussed is CAT; the disease is neoplasm.